These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8628414)

  • 21. [Digestive system diseases and fecal occult blood].
    Kobashi E
    Rinsho Byori; 1998 Mar; Suppl 107():138-44. PubMed ID: 9569753
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal occult blood testing options.
    Lastella VP
    Gastroenterology; 2006 Jan; 130(1):285; author reply 285. PubMed ID: 16401498
    [No Abstract]   [Full Text] [Related]  

  • 24. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 25. Fecal occult blood tests often misinterpreted by providers.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Mar; 14(5):5-7. PubMed ID: 12817576
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.
    Rozen P; Waked A; Vilkin A; Levi Z; Niv Y
    Med Sci Monit; 2006 Jun; 12(6):MT27-32. PubMed ID: 16733493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ColoCARE versus Hemoccult SENSA for fecal occult blood testing in high-risk patients.
    Wise GR; Foliente RL; Chen YK
    Am J Gastroenterol; 1996 Aug; 91(8):1671-2. PubMed ID: 8759699
    [No Abstract]   [Full Text] [Related]  

  • 28. [Screening for colorectal cancer: importance of fecal occult blood test].
    De Paula AO
    Acta Gastroenterol Latinoam; 1999; 29(2):79-81. PubMed ID: 10491720
    [No Abstract]   [Full Text] [Related]  

  • 29. In-office fecal occult blood tests fail to detect cancer.
    Health News; 2005 May; 11(5):8. PubMed ID: 15884165
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 31. [Early detection of colon carcinomas. Diagnostic series: fecal occult blood].
    Janssen K
    MMW Fortschr Med; 2000 Nov; 142(46):46. PubMed ID: 11132313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of diagnostic possibility of clinical tests].
    Rinsho Byori; 2000 Aug; Suppl 113():34-50. PubMed ID: 11103142
    [No Abstract]   [Full Text] [Related]  

  • 33. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.
    Simon JB
    N Engl J Med; 1998 Apr; 338(16):1151-2; discussion 1154-5. PubMed ID: 9545367
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the fecal occult blood test and benign anal disorders.
    Sasaki K; Kunimoto M; Hirata K
    Hepatogastroenterology; 2001; 48(38):445-7. PubMed ID: 11379329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The law of unintended consequences: The Joint Commission regulations and the digital rectal examination.
    Adams BD; McHugh KJ; Bryson SA; Dabulewicz J
    Ann Emerg Med; 2008 Feb; 51(2):197-201, 201.e1. PubMed ID: 17961818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal-occult-blood test screening for colorectal cancer.
    Zacks M
    J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.